Cargando…

Do not jump too quickly to conclusions

A great deal of misinformation has been promulgated about mammography screening. For example, there is no biological or scientific support for the use of the age of 50 years as a threshold for screening. Mammography screening can reduce deaths from breast cancer even if the rate of advanced cancers...

Descripción completa

Detalles Bibliográficos
Autor principal: Kopans, Daniel B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680917/
https://www.ncbi.nlm.nih.gov/pubmed/22824314
http://dx.doi.org/10.1186/bcr3213
_version_ 1782273176049287168
author Kopans, Daniel B
author_facet Kopans, Daniel B
author_sort Kopans, Daniel B
collection PubMed
description A great deal of misinformation has been promulgated about mammography screening. For example, there is no biological or scientific support for the use of the age of 50 years as a threshold for screening. Mammography screening can reduce deaths from breast cancer even if the rate of advanced cancers is not decreased. The suggestion that screening results in massive amounts of overdiagnosis is based upon faulty methodology. The results reported in the recent study by Nederend and colleagues may be due to the screening interval and thresholds used for intervention. What is clear, however, is that they do not show that screening is ineffective.
format Online
Article
Text
id pubmed-3680917
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36809172013-06-25 Do not jump too quickly to conclusions Kopans, Daniel B Breast Cancer Res Editorial A great deal of misinformation has been promulgated about mammography screening. For example, there is no biological or scientific support for the use of the age of 50 years as a threshold for screening. Mammography screening can reduce deaths from breast cancer even if the rate of advanced cancers is not decreased. The suggestion that screening results in massive amounts of overdiagnosis is based upon faulty methodology. The results reported in the recent study by Nederend and colleagues may be due to the screening interval and thresholds used for intervention. What is clear, however, is that they do not show that screening is ineffective. BioMed Central 2012 2012-07-23 /pmc/articles/PMC3680917/ /pubmed/22824314 http://dx.doi.org/10.1186/bcr3213 Text en Copyright ©2012 BioMed Central Ltd
spellingShingle Editorial
Kopans, Daniel B
Do not jump too quickly to conclusions
title Do not jump too quickly to conclusions
title_full Do not jump too quickly to conclusions
title_fullStr Do not jump too quickly to conclusions
title_full_unstemmed Do not jump too quickly to conclusions
title_short Do not jump too quickly to conclusions
title_sort do not jump too quickly to conclusions
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680917/
https://www.ncbi.nlm.nih.gov/pubmed/22824314
http://dx.doi.org/10.1186/bcr3213
work_keys_str_mv AT kopansdanielb donotjumptooquicklytoconclusions